New Technologies in Cell Therapy Manufacturing: Invetech presents at the 18th Annual ISCT Meeting

16 May 2012

Update: David James will also be joining the roundtable discussion 'Cell Therapy industrialization challenges: From R&D to commercialization'. View details here.

David James

David James, Invetech's Director of Life Science and Pharmaceutical, will present at the 18th Annual ISCT meeting, to be held in Seattle, Washington. The ISCT is a premier global association started to help drive the translation of scientific research to deliver innovative cellular therapies to patients.

David, in conjunction with key industry leaders, will address key issues influencing strategies for cell therapy commercialization. David will discuss approaches for advanced automation for cellular processing, including the technologies available today, and why, when and how to start planning for, and implementing automation during clinical development.

New Technologies in Cell Therapy Manufacturing
Technical Applications Track 9: Point of Care Devices in Cell Therapy
When: Friday June 8, 7:30 – 8:30am

18th Annual ISCT Meeting
June 5-8, 2012
Sheraton Seattle, Seattle, WA, USA

For more information visit the ISCT website.

Further Press Information

Alan Morris, Phone: +613 9211 7815, Fax: +613 9211 7703. Media Inquiries.